The 44 references in paper , статья Редакционная (2014) “Бронхолегочные осложнения заболеваний нервно-мышечной системы: клинические рекомендации Испанского общества пульмонологов и торакальных хирургов // Pulmonary complications of neuromuscular disease: clinical guidelines of the Spanish society of pulmonology and thoracic surgery” / spz:neicon:pulmonology:y:2013:i:6:p:11-20

1
Howard R.S., Wiles C.M., Hirsch N.P., Spencer G.T. Respiratory involvement in primary muscle disorders: assessment and management. Quart. J. Med. 1993; 86: 175–189.
(check this in PDF content)
2
Simonds A.K. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130: 1879–1886.
(check this in PDF content)
3
Farrero E., Prats E., Povedano M. et al.Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005; 127: 2132–2138.
(check this in PDF content)
4
Schünemann H.J., Jaeschke R., Cook D. et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Crit. Care Med. 2006; 174: 605–614.
(check this in PDF content)
5
Ambrosino N., CarpenéN., Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur. Respir. J. 2009; 34: 444–451.
(check this in PDF content)
6
Díaz7Lobato S., Ruiz7Cobos A., García Rýo F.J., Villamor Leуn J. Fisiopatologia de la insuficiencia respiratoria de origen neuromuscular. Rev. Neurol. 2001; 32: 91–95.
(check this in PDF content)
7
Rabinstein A.A. Update on respiratory management of critically ill neurologic patients. Curr. Neurol. Neurosci. Rep. 2005; 5: 476–482.
(check this in PDF content)
8
Miller R.G., Jackson C.E., Kasarskis E.J. et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218–1226.
(check this in PDF content)
9
Vincken W.G., Elleker M.G., Cosio M.G. Flow-volume loop changes reflecting respiratory muscle weakness in chronic neuromuscular disorders. Am. J. Med. 1987; 83: 673–680.
(check this in PDF content)
10
Hughes R.A., Wijdicks E.F., Benson E. et al. Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barrésyndrome. Arch. Neurol. 2005; 62:
(check this in PDF content)
11
4–1198. 11.Mayos M., Giner J., Casan P., Sanchis J. Measurement of maximal static respiratory pressures at the mouth with different air leaks. Chest 1991; 100: 364–366.
(check this in PDF content)
12
Servera E., Sancho J., Zafra M.J. Tos y enfermedades neuromusculares. Manejo no invasivo de las secreciones respiratorias. Arch. Bronconeumol. 2003; 39: 418–427.
(check this in PDF content)
13
Morgan R.K., McNally S., Alexander M. et al.Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am. J. Respir. Crit. Care Med. 2005; 171: 269–274.
(check this in PDF content)
14
Hart N., Sylvester K., Ward S. et al. Evaluation of an inspiratory muscle trainer in healthy humans. Respir. Med. 2001; 95: 526–531.
(check this in PDF content)
15
Lloyd T., Tang Y.M., Benson M.D., King S.Diaphragmatic paralysis: the use of M mode ultrasound for diagnosis in adults. Spinal Cord 2006; 44: 505–508.
(check this in PDF content)
16
AGA technical review on management of oropharyngeal dysphagia. Gastroenterology 1999; 116: 455–478.
(check this in PDF content)
17
ClavéP., Arreola A., Velasco M. et al.Diagnуstico y tratamiento de la disfagia orofaringea funcional. Aspectos de interés para el cirujano digestivo. Cir. Esp. 2007; 82: 64–77.
(check this in PDF content)
18
Lim S.H.B., Lieu P.K., Phua S.Y. et al. Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001; 16: 1–6.
(check this in PDF content)
19
Bhakta D., Groh W.J. Cardiac function tests in neuromuscular diseases. Neurol. Clin. 2004; 22: 591–617.
(check this in PDF content)
20
Goldstein L.B., El Husseini N. Neurology and cardiology: points of contact. Rev. Esp. Cardiol. 2011; 64: 319–327.
(check this in PDF content)
21
Gregoratos G., Abrams J., Epstein A. et al. ACC / AHA / NASPE 2002 Guideline update for implantation of cardiac pacemarkers and antiarrhythmia device. Circulation 2002; 106: 2145–2161.
(check this in PDF content)
22
Kang S.W., Bach J.R. Maximum insufflation capacity: the relationships with vital capacity and cough flows for patients with neuromuscular disease. Am. J. Phys. Med. Rehabil. 2000; 79: 222–227.
(check this in PDF content)
23
Ishikawa Y., Bach J.R.Physical medicine respiratory muscle aids to avert respiratory complications of pediatric chest wall and vertebral deformity and muscle dysfunction. Eur. J. Phys. Rehabil. Med. 2010; 46: 581–597.
(check this in PDF content)
24
Laffont I., Bensmail D., Lortat7Jacob S. Intermittent positive-pressure breathing effects in patients with high spinal cord injury. Arch. Phys. Med. Rehab. 2008; 89: 1575–1579.
(check this in PDF content)
25
Guerin C., Vincent B., Petitjean T. et al. The short-term effects of intermittent positive pressure breathing treatments on ventilation in patients with neuromuscular disease. Respir. Care 2010; 55: 866–872.
(check this in PDF content)
26
AARC Clinical Practice Guideline. Intermittent positive pressure breathing-2003 revision & update. Respir. Care 2003; 48: 540–546.
(check this in PDF content)
27
Bento J., Gonçalves M., Silva N. et al. Indications and compliance of home mechanical insufflation-exsufflation in patients with neuromuscular diseases. Arch. Bronconeumol. 2010; 46: 420–425.
(check this in PDF content)
28
Sancho J., Servera E., Díaz J., Marín J.Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004; 125: 1400–1405.
(check this in PDF content)
29
Annane D., Quera7Salva M.A., Lofaso F. et al. Mechanisms underlying the effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur. Respir. J. 1999; 13: 157–162.
(check this in PDF content)
30
Nickol A.N., Hart N., Hopkinson N.S. et al. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax 2005; 60: 754–760.
(check this in PDF content)
31
Hess D.R.Noninvasive ventilation in neuromuscular diseases: equipment and application. Respir. Care 2006; 51: 896–912.
(check this in PDF content)
32
Make B., Hill N., Goldberg A. et al.Mechanical ventilation beyond the intensive care unit. Report of a Consensus Conference of the American College of Chest Physicians. Chest 1998; 113: 289–344.
(check this in PDF content)
33
Kohorts J., Blakely P., Dockter C., Pruit W. AARC clinical practice guideline: longterm invasive mechanical ventilation in home-2007 revision & update. Respir. Care 2007; 52: 1056–1062.
(check this in PDF content)
34
McKim D.A., Road J., Avendano M. et al. Home mechanical ventilation: a Canadian Thoracic Society Clinical Practice Guideline. Can. Respir. J. 2011; 18: 197–215.
(check this in PDF content)
35
Sancho J., Servera E., Dás J.L. et al.Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival. Thorax 2011; 66: 948–952.
(check this in PDF content)
36
Antequera J.M., Barbero J., Bátiz J. et al. Ética en cuidados paliativos. Guias de ética en la práctica clinica. Fundaciуn de Ciencias de la Salud. Available from: www.saludcastil7 layleon.es [accessed 25.01.13].
(check this in PDF content)
37
Meisel A., Snyder L., Quill T.Seven legal barriers to end-oflife care: myths, realities, and grains of truth. J.A.M.A. 2000; 284: 2495–2501.
(check this in PDF content)
38
Lanken P., Terry P., DeLisser H.M.An Official American Thoracic Society Clinical Policy Statement: palliative care for patients with respiratory diseases and critical illnesses. Am. J. Respir. Crit. Care Med. 2008; 177: 912–927.
(check this in PDF content)
39
Aguilar M., Badenes D., Gelonch O. Enfermedades neurolуgicas crуnicas y abordaje interdisciplinar. Summa Neurol. 2002; 1: 38–41.
(check this in PDF content)
40
Escarrabill J., Dáz S., Masa J.F. et al.Hospital based longterm home respiratory care in Spain. Chest 1999; 116 (Suppl.): 318.
(check this in PDF content)
41
Escarrabill J., Farrero E., Prats E. Unidad funcional respiratoria multidisciplinar. Med. Clin. (Barc.). 1996; 107: 438–439.
(check this in PDF content)
42
Corr B., Frost E., Traynor B.J., Hardiman O. Service provision for patients with ALS/MND: a cost-effective multidisciplinary approach. J. Neurol. Sci. 1998; 160 (Suppl. 1): S141–S145.
(check this in PDF content)
43
Traynor B.J., Alexander M., Corr B. et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J. Neurol. Neurosurg. Psychiatry. 2003; 74: 1258–1261.
(check this in PDF content)
44
Zoccolella S., Beghi E., Palagano G. et al.ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J. Neurol. 2007; 254: 1107–1112. Поступила 06.01.14 УДК 616.248!085
(check this in PDF content)